|

Study on Plasmablastic Lymphoma Patients

RECRUITINGSponsored by Fondazione Italiana Linfomi - ETS
Actively Recruiting
SponsorFondazione Italiana Linfomi - ETS
Started2025-02-14
Est. completion2028-02-01
Eligibility
Age15 Years+
Healthy vol.Accepted
View on ClinicalTrials.gov →

NCT06781359

Summary

This is an observational, multicenter, international and retrospective study, that aims to collect data on clinical and pathological characteristics, treatment regimens, outcome, and prognostic factors (clinical, biomarkers and/or radio-metabolic) in patients affected by PBL.

Eligibility

Age: 15 Years+Healthy volunteers accepted
Inclusion Criteria:

* Diagnosis of plasmablastic lymphoma (PBL) between Jan 1st 2000, and Dec 31st 2022
* Histologically confirmed plasmablastic lymphoma (PBL) diagnosis according to local pathological report
* Age \> 18 years old
* Availability of complete medical records
* Availability of histopathological material requested by the study

Exclusion Criteria:

* Any other histology than PBL
* Lack of complete medical records
* Lack of histopathological material requested by the study

Conditions2

CancerPlasmablastic Lymphoma

Browse More Trials

Cancer trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.